pubmed-article:15808765 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15808765 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15808765 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:15808765 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
pubmed-article:15808765 | lifeskim:mentions | umls-concept:C0001645 | lld:lifeskim |
pubmed-article:15808765 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
pubmed-article:15808765 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
pubmed-article:15808765 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
pubmed-article:15808765 | lifeskim:mentions | umls-concept:C0026538 | lld:lifeskim |
pubmed-article:15808765 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:15808765 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:15808765 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:15808765 | pubmed:dateCreated | 2005-4-5 | lld:pubmed |
pubmed-article:15808765 | pubmed:abstractText | The aim of this study was to determine echocardiographic predictors of outcome in patients with advanced heart failure (HF) due to severe left ventricular (LV) systolic dysfunction in the Beta-blocker Evaluation of Survival Trial (BEST). | lld:pubmed |
pubmed-article:15808765 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15808765 | pubmed:language | eng | lld:pubmed |
pubmed-article:15808765 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15808765 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15808765 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15808765 | pubmed:month | Apr | lld:pubmed |
pubmed-article:15808765 | pubmed:issn | 0735-1097 | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:KwaBB | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:GrayburnPaul... | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:DeMariaAnthon... | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:EichhornEric... | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:St John... | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:AppletonChris... | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:GreenbergBarr... | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:LowesBrianB | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:PlehnJonathan... | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:RahkoPeterP | lld:pubmed |
pubmed-article:15808765 | pubmed:author | pubmed-author:BEST Trial... | lld:pubmed |
pubmed-article:15808765 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15808765 | pubmed:day | 5 | lld:pubmed |
pubmed-article:15808765 | pubmed:volume | 45 | lld:pubmed |
pubmed-article:15808765 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15808765 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15808765 | pubmed:pagination | 1064-71 | lld:pubmed |
pubmed-article:15808765 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:meshHeading | pubmed-meshheading:15808765... | lld:pubmed |
pubmed-article:15808765 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15808765 | pubmed:articleTitle | Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST). | lld:pubmed |
pubmed-article:15808765 | pubmed:affiliation | Echocardiographic Core Laboratory, Baylor University Medical Center, 621 North Hall Street, Dallas, TX, 75226. paulgr@baylorhealth.edu | lld:pubmed |
pubmed-article:15808765 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15808765 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:15808765 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:15808765 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:15808765 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15808765 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15808765 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15808765 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15808765 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15808765 | lld:pubmed |